Accurately quantifying optical absorption coefficient using acoustic spectra of photoacoustic signals. Optical absorption is closely associated with many physiological parameters, such as the concentration and oxygen saturation of hemoglobin, and it can be used to quantify the concentrations of non-fluorescent molecules. A sample is illuminated by, for example, a pulsed laser and following the absorption of optical energy, a photoacoustic pressure is generated via thermo-elastic expansion. The acoustic waves then propagate and are detected by a transducer. The optical absorption coefficient of the sample is quantified from spectra of the measured photoacoustic signals. Factors, such as system bandwidth and acoustic attenuation, may affect the quantification but are canceled by dividing the acoustic spectra measured at multiple optical wavelengths.
|
9. A system for quantifying an absolute optical absorption coefficient of a volume of an object, said system comprising:
a light source for emitting a first light pulse having a first wavelength and a second light pulse having a second wavelength;
a focusing element for focusing the first light pulse and the second light pulse into a volume of the object;
an acoustic transducer for receiving a first acoustic wave emitted by the object in response to the volume of the object absorbing the first light pulse and a second acoustic wave emitted by the object in response to the volume of the object absorbing the second light pulse; and
a controller for performing a transformation on the received first acoustic wave and second acoustic wave to generate a first acoustic spectrum and a second acoustic spectrum, respectively, and quantifying the absolute absorption coefficient of the volume of the object as a function of the first acoustic spectrum and the second acoustic spectrum.
1. A method of quantifying an absolute optical absorption coefficient of an object, said method comprising:
focusing a first light pulse emitted by a light source into a volume of the object, wherein the first light pulse has a first wavelength;
receiving at an acoustic transducer a first acoustic wave emitted by the object in response to receiving the first light pulse;
performing on a controller a transformation on the received first acoustic wave to generate a first acoustic spectrum;
focusing a second light pulse emitted by the light source into the volume of the object, wherein the second light pulse has a second wavelength;
receiving at the acoustic transducer a second acoustic wave emitted by the object in response to receiving the second light pulse;
performing on the controller a transformation on the received second acoustic wave to generate a second acoustic spectrum; and
quantifying the absolute absorption coefficient of the volume of the object, wherein the absolute absorption coefficient is a function of the first acoustic spectrum and the second acoustic spectrum.
15. A system for generating an image of an object and quantifying an absolute optical absorption coefficient of a volume of an object, said system comprising:
a light source for emitting a first light pulse having a first wavelength and a second light pulse having a second wavelength;
a focusing element for focusing the first light pulse and the second light pulse into a volume of a plurality of volumes of the object;
an acoustic transducer for receiving a first acoustic wave produced by the object in response to the volume of the object absorbing the first light pulse and a second acoustic wave produced by the object in response to the volume of the object absorbing the second light pulse;
a controller for performing a transformation on the received first acoustic wave and second acoustic wave to generate a first acoustic spectrum and a second acoustic spectrum, respectively, quantifying the absolute absorption coefficient of the volume of the object as a function of the first acoustic spectrum and the second acoustic spectrum and for reconstructing an image from acoustic spectra detected from the plurality of volumes of the object; and
a scanner for altering a spatial relationship between the object and the focusing element after the first acoustic wave and the second acoustic wave are detected by the acoustic transducer for the volume such that the first light pulse and the second light pulse are focused into another volume of the plurality of volumes of the object.
2. The method of
3. The method of
4. The method of
5. The method of
7. The method of
8. The method of
10. The system of
the transformation performed by the controller on the received first acoustic wave to generate the first acoustic spectrum is a Fourier transformation; and
the transformation performed by the controller on the received second acoustic wave to generate the second acoustic spectrum is a Fourier transformation.
11. The system of
12. The system of
13. The system of
14. The system of
16. The system of
the transformation performed by the controller on the received first acoustic wave to generate the first acoustic spectrum is a Fourier transformation; and
the transformation performed by the controller on the received second acoustic wave to generate the second acoustic spectrum is a Fourier transformation.
17. The system of
18. The system of
19. The system of
20. The system of
|
This application claims the benefit of U.S. Provisional Patent Application No. 61/322,605 filed Apr. 9, 2010, which is hereby incorporated by reference in its entirety.
This invention was made with government support under grant R01 EB008085, awarded by the U.S. National Institutes of Health. The government has certain rights in the invention.
The embodiments described herein relate generally to photoacoustic scanning methods and apparatus and, more particularly, to a method and a system for determining an optical absorption coefficient by an object using acoustic spectra.
Total, oxygenated, and deoxygenated hemoglobin concentrations ([HbT], [HbO2], and [HbR], respectively) are fundamental pathophysiological parameters in biomedicine. For example, abnormally low [HbT] may be caused by loss of blood, nutritional deficiency, chemotherapy, inflammation, kidney failure or bone marrow problems, while abnormally high [HbT] may be related to exposure to high altitude, smoking, dehydration and tumors. Blood oxygen saturation (sO2), which is defined as [HbO2] divided by [HbT], is vital in understanding brain hemodynamics in response to sensory stimulations, monitoring healing of burns and wounds, and evaluating the effectiveness of chemotherapy and radiotherapy on tumors. Several techniques have been developed to quantify hemoglobin concentration and sO2 in vivo, including near-infrared spectroscopy (NIRS), blood oxygen level dependent (BOLD) contrast magnetic resonance imaging (MRI), electron paramagnetic resonance imaging (EPRI), positron emission tomography (PET), and single photon emission computed tomography (SPECT). However, all of these modalities have disadvantages. For example, at least some of these modalities have poor spatial resolution, relative quantification, and undesirable contrast agent injection. Photoacoustic (PA) tomography (PAT) has already demonstrated its ability to monitor biological hemodynamic functions without using exogenous contrast agents. Quantitative PAT is challenging, because compensating for the fluence in quantitative in vivo photoacoustic tomography is difficult, and factors, such as the tissue acoustic attenuation and the imaging system bandwidth, also affect the quantification accuracy.
In one aspect, a photoacoustic imaging method includes illuminating an object using a light beam emitted by a light source, and detecting a pressure wave emitted by the object using an acoustic transducer, wherein the pressure wave is induced by the object in response to the light beam (e.g., light pulse). The object is illuminated with at least two light pulses having different wavelengths, and the absorption coefficient of the object is determined from the detected pressure waves. The method also includes calculating an amount of optical energy that is absorbed by the object from the light beam, based at least on the pressure.
The embodiments described herein may be better understood by referring to the following description in conjunction with the accompanying drawings.
While the making and using of various embodiments of the present disclosure are discussed in detail below, it should be appreciated that the present disclosure provides many applicable inventive concepts that can be embodied in a wide variety of specific contexts. The specific embodiments discussed herein are merely illustrative of specific ways to make and use the disclosure and do not delimit the scope of the disclosure.
To facilitate the understanding of the embodiments described herein, a number of terms are defined below. The terms defined herein have meanings as commonly understood by a person of ordinary skill in the areas relevant to the present disclosure. Terms such as “a,” “an,” and “the” are not intended to refer to only a singular entity, but rather include the general class of which a specific example may be used for illustration. The terminology herein is used to describe specific embodiments of the disclosure, but their usage does not delimit the disclosure, except as outlined in the claims.
To be consistent with the commonly used terminology, whenever possible, the terms used herein will follow the definitions recommended by the Optical Society of America (OCIS codes).
In some embodiments, the term “photoacoustic microscopy” refers generally to a photoacoustic imaging technology that detects pressure waves generated by light absorption in the volume of a material (such as biological tissue) and propagated to the surface of the material. In other words, photoacoustic microscopy is a method for obtaining three-dimensional images of the optical contrast of a material by detecting acoustic or pressure waves traveling from the object. Imaging resolution is on the micrometer scale.
In some embodiments, the term “photoacoustic tomography” also refers to a photoacoustic imaging technology that detects acoustic or pressure waves generated by light absorption in the volume of a material (such as biological tissue) and propagated to the surface of the material. The emphasis is sometimes on photoacoustic computed tomography, i.e., cross-sectional or three-dimensional photoacoustic imaging based on computer reconstruction, although the most general definition of photoacoustic tomography encompasses photoacoustic microscopy.
In some embodiments, the terms “reflection mode” and “transmission mode” refer generally to a laser photoacoustic microscopy system that employs the detection of acoustic or pressure waves transmitted from the volume of their generation to the optically irradiated surface and a surface that is opposite to, or substantially different from, the irradiated surface, respectively.
In some embodiments, the term “time-resolved detection” refers generally to the recording of the time history of a pressure wave with a temporal resolution sufficient to reconstruct the pressure wave profile.
In some embodiments, the term “photoacoustic waves” refers generally to pressure waves produced by light absorption.
In photoacoustic imaging, a sample is illuminated, usually by a pulsed laser, and following the absorption of optical energy, an initial pressure is generated via thermo-elastic expansion. The photoacoustic waves then propagate and are detected by acoustic or ultrasonic sensors. The strength of the initial pressure is directly proportional to the absorbed optical energy in the tissue and, therefore, multi-wavelength photoacoustic measurements may yield optical absorption spectral information. Since ultrasound scattering is much weaker than optical scattering in biological tissues, photoacoustic tomography is capable of high resolution imaging at depths beyond the optical transport mean free path. Moreover, because photoacoustic imaging inherently exploits optical absorption contrast, it usually has a higher sensitivity to optical absorption than other optical imaging technologies. By measuring the optical absorption spectrum with photoacoustic imaging, sO2 may be quantified in the same way near infrared spectroscopy (NIRS) quantifies sO2, except with high spatial resolution and sensitivity.
Photoacoustic images are spatial mappings of the absorbed optical energy A({right arrow over (r)}) (Jm−3), which is the product of the optical absorption coefficient μa({right arrow over (r)},λ) (m−1) and the fluence F({right arrow over (r)}) (Jm−2). To obtain the intrinsic tissue property μa({right arrow over (r)},λ), there is a need to compensate for the extrinsic quantity F({right arrow over (r)}). Since the optical parameters for tissues are usually heterogeneous and unknown, the fluence varies from case to case and is difficult to model. As a consequence, compensating for the fluence in quantitative in vivo photoacoustic tomography is a challenge.
Currently, fluence compensation can be done invasively or non-invasively. The invasive method includes positioning an optical absorber with a known spectrum close to the region of interest, and then normalizing the measured photoacoustic signals from the objects with the amplitudes of the photoacoustic signals from the optical absorber having a known spectrum. Alternatively, the incident fluence may be estimated by measuring light transmission through a sample of excised tissue of the same type as the tissue overlaying a region of interest. The non-invasive method involves solving the radiative transfer equation (RTE) and photoacoustic wave equations with iterative algorithms. Both of these methods are based on the linear relationship between the local fluence incident on the blood vessel, acquired either by experimental measurements or numerical simulation, and the peak amplitude of the photoacoustic signal.
A temporal profile of the photoacoustic signal is used to quantify the optical absorption coefficients. This temporal method is self-calibrating since it depends on the relative temporal profile rather than the absolute amplitude of the photoacoustic signal. Therefore, the temporal profile is less dependent on changes in the optical properties of overlying tissues. However, since the temporal profile is distorted by various factors, such as the limited bandwidth of acoustic detectors and frequency-dependent acoustic attenuation of the sample or region of interest, linear translation of the temporal profile to the optical absorption may be inaccurate.
As will be described in greater detail below, embodiments of the present disclosure provide a method for quantifying the optical absorption coefficient using the acoustic spectra of the photoacoustic signals. By carefully investigating the factors involved in generating the acoustic spectrum, the effects of detector bandwidth and acoustic attenuation are eliminated, as shown later. At least some embodiments of the method are self-calibrating since it deals only with the relative change in various acoustic frequencies. The acoustic spectrum S(ω) of the received photoacoustic signal depends on three factors: 1) the ‘real’ object spectrum O(ω,λ) measured with unit fluence, which is related to the target object's shape, size, optical properties, and fluence incident directions; 2) the system dependent response H(ω), which is the Fourier transform of the photoacoustic signal from an ideal point absorber measured with this system without acoustic attenuation in the tissue; and 3) the tissue related acoustic attenuation effect a(ω), which is related to the acoustic properties of the tissue that lies between the target objects (e.g., region of interest) and the detector. Based on a system linearity assumption, the above factors lead to the expression S(ω,λ)=F(λ)O(ω,λ)H(ω)a(ω). The last two terms remain unchanged when samples are measured with the same system under the same condition, and therefore are usually cancelable. An example is where light at various optical wavelengths is used to excite one blood vessel. Therefore, by dividing the photoacoustic acoustic spectrum measured at one optical wavelength by the spectrum measured at another wavelength, the system dependent effects and the acoustic attenuation effect may be eliminated. As such, the absolute value of μa may be quantified with this method even though F varies with the optical wavelength. By contrast, previous methods can quantify only the relative value of μa.
As a feasibility study, this idea has been implemented and validated using one form of photoacoustic imaging, optical resolution photoacoustic microscopy (OR-PAM), where the object spectrum O(ω,λ) may be relatively easily modeled. Referring to
O(t,λ)=μa(λ)exp[−μa(λ)ct] Eq. (1)
where c is the speed of sound in the biological tissue. Performing a Fourier transformation of Eq. (1) leads to Equation (2):
Moreover, if the photoacoustic signals of the blood vessel are measured at two optical wavelengths, the ratio of the spectra of the photoacoustic signals may be written as shown in Equation (3):
Furthermore, the absolute values of μa(λ1), μa(λ2), and F(λ1)/F(λ2) may be derived by fitting the ratio of Eq. (3). The assumption of laser beam collimation within the blood vessel for Eqs. (1)-(3) is valid within and far from the optical focal zone. Otherwise, the 3D Gaussian beam profile should be considered. Here, the Rayleigh range of the Gaussian beam is approximately 30 μm, which is comparable to the optical penetration depth in blood around 585 nm.
As shown in
In a phantom study, original black ink was diluted with water in six ratios ranging from 1:1 to 1:6. The original and diluted ink samples were sequentially placed in a container, sealed with plastic membrane, and then the container was placed in a water tank. Photoacoustic A-line signals were acquired from these samples. The acoustic spectra of the photoacoustic signals are shown in
In an in vivo experiment, a region measuring approximately 1 square millimeter (mm2) in a nude mouse ear was imaged with two optical wavelengths of 561 nanometers (nm) and 570 nm.
In Eq. (4), λ1 and λ2 are the two wavelengths, and εox and εde are the known molar extinction coefficients of oxy- and deoxyhemoglobin, respectively. According to the sO2 values, V1 and V2 were identified to be an arteriole-venule pair. The incident fluence ratio at the two optical wavelengths F(λ1)/F(λ2) was also quantified for both vessels. In this special case, the two vessels are embedded at a similar depth, and the optical and the acoustic properties of the overlying tissue are comparable. Here, the quantified fluence ratios turned out to be the same for V1 and V2. If the wavelength-dependent fluence variations are ignored by simply assuming F(λ1)/F(λ2)=1, as shown in the last column of Table 1, the quantified sO2 values become inaccurate by approximately 8% and 11% for the artery and the vein, respectively.
TABLE 1
μa(λ1)
μa(λ2)
[HbT]
[HbO2]
[HbR]
sO2
(cm−1)
(cm−1)
F(λ2)/F(λ1)
(g/L)
(g/L)
(g/L)
sO2
F2/F1 = 1
V1
143 ± 3
188 ± 4
0.96 ± 0.01
110.6 ± 8.1
106.2 ± 4.3
4.4 ± 3.8
0.96 ± 0.04
0.88
(Artery)
V2
159 ± 4
186 ± 5
0.96 ± 0.01
110.2 ± 9.2
77.1 ± 4.9
33.1 ± 4.3
0.70 ± 0.07
0.62
(Vein)
Embodiments of the method may be applied in the optical diffusive regime with photoacoustic microscopy, whose lateral resolution relies on the acoustic focus (e.g., ˜50 μm at 50 MHz acoustic frequency). As shown in
F(z)=πR2∫∫S′exp(−μa√{square root over (x′2+y′2+z′2)})dx′dy′=F0π2R2∫0∞exp(−μa√{square root over (u+z2)})du Eq. (6)
where R is the radius of the acoustic focus 510. The object spectrum O(ω,λ) may then be calculated using Fourier transformation, where z is first converted to time t through z=ct. Similar to the case of OR-PAM, the system-dependent response H(ω) and the tissue related acoustic attenuation effect a(ω) are canceled by dividing, at each acoustic frequency, the acoustic spectra measured at two optical wavelengths.
To increase the accuracy of this method, an acoustic transducer with an appropriate bandwidth is selected. The acoustic spectrum of the photoacoustic signal is related to the light penetration depth. Therefore, the central frequency of the transducer should vary with the penetration depth to achieve the best signal to noise ratio (SNR). Therefore, the central frequency of the transducer should match the penetration depth to maximize signal to noise ratio (SNR). Moreover, SNR is usually low at high acoustic frequencies due to acoustic attenuation. O(ω,λ), H(ω), and a(ω) are all band-limited, and in an exemplary embodiment, H(ω) is chosen to match O(ω,λ) and a(ω).
Referring to
It will be understood that the particular embodiments described herein are shown by way of illustration and not as limitations of the disclosure. The principal features of this disclosure may be employed in various embodiments without departing from the scope of the disclosure. Those of ordinary skill in the art will recognize numerous equivalents to the specific procedures described herein. Such equivalents are considered to be within the scope of this disclosure and are covered by the claims.
All of the compositions and/or methods disclosed and claimed herein may be made and/or executed without undue experimentation in light of the present disclosure. While the compositions and methods of this disclosure have been described in terms of the embodiments included herein, it will be apparent to those of ordinary skill in the art that variations may be applied to the compositions and/or methods and in the steps or in the sequence of steps of the method described herein without departing from the concept, spirit, and scope of the disclosure. All such similar substitutes and modifications apparent to those skilled in the art are deemed to be within the spirit, scope, and concept of the disclosure as defined by the appended claims.
It will be understood by those of skill in the art that information and signals may be represented using any of a variety of different technologies and techniques (e.g., data, instructions, commands, information, signals, bits, symbols, and chips may be represented by voltages, currents, electromagnetic waves, magnetic fields or particles, optical fields or particles, or any combination thereof). Likewise, the various illustrative logical blocks, modules, circuits, and algorithm steps described herein may be implemented as electronic hardware, computer software, or combinations of both, depending on the application and functionality. Moreover, the various logical blocks, modules, and circuits described herein may be implemented or performed with a general purpose processor (e.g., microprocessor, conventional processor, controller, microcontroller, state machine or combination of computing devices), a digital signal processor (“DSP”), an application specific integrated circuit (“ASIC”), a field programmable gate array (“FPGA”) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. Similarly, steps of a method or process described herein may be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module may reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art. Although preferred embodiments of the present disclosure have been described in detail, it will be understood by those skilled in the art that various modifications can be made therein without departing from the spirit and scope of the disclosure as set forth in the appended claims.
A controller, computing device, or computer, such as described herein, includes at least one or more processors or processing units and a system memory. The controller typically also includes at least some form of computer readable media. By way of example and not limitation, computer readable media may include computer storage media and communication media. Computer storage media may include volatile and nonvolatile, removable and non-removable media implemented in any method or technology that enables storage of information, such as computer readable instructions, data structures, program modules, or other data. Communication media typically embody computer readable instructions, data structures, program modules, or other data in a modulated data signal such as a carrier wave or other transport mechanism and include any information delivery media. Those skilled in the art should be familiar with the modulated data signal, which has one or more of its characteristics set or changed in such a manner as to encode information in the signal. Combinations of any of the above are also included within the scope of computer readable media.
This written description uses examples to disclose the disclosure, including the best mode, and also to enable any person skilled in the art to practice the disclosure, including making and using any devices or systems and performing any incorporated methods. The patentable scope of the disclosure is defined by the claims, and may include other examples that occur to those skilled in the art. Such other examples are intended to be within the scope of the claims if they have structural elements that do not differ from the literal language of the claims, or if they include equivalent structural elements with insubstantial differences from the literal language of the claims.
Patent | Priority | Assignee | Title |
10016137, | Nov 22 2017 | HI LLC | System and method for simultaneously detecting phase modulated optical signals |
10299682, | Nov 22 2017 | HI LLC | Pulsed ultrasound modulated optical tomography with increased optical/ultrasound pulse ratio |
10335036, | Nov 22 2017 | HI LLC | Pulsed ultrasound modulated optical tomography using lock-in camera |
10368752, | Mar 08 2018 | HI LLC | Devices and methods to convert conventional imagers into lock-in cameras |
10420469, | Nov 22 2017 | HI LLC | Optical detection system for determining neural activity in brain based on water concentration |
11058301, | Nov 22 2017 | HI LLC | System and method for simultaneously detecting phase modulated optical signals |
11206985, | Apr 13 2018 | HI LLC | Non-invasive optical detection systems and methods in highly scattering medium |
11291370, | Mar 08 2018 | HI LLC | Devices and methods to convert conventional imagers into lock-in cameras |
11530979, | Aug 14 2018 | California Institute of Technology | Multifocal photoacoustic microscopy through an ergodic relay |
11592652, | Sep 04 2018 | California Institute of Technology | Enhanced-resolution infrared photoacoustic microscopy and spectroscopy |
11672426, | May 10 2017 | California Institute of Technology | Snapshot photoacoustic photography using an ergodic relay |
11857316, | May 07 2018 | HI LLC | Non-invasive optical detection system and method |
9730589, | Oct 31 2013 | Canon Kabushiki Kaisha | Examined-portion information acquisition apparatus |
Patent | Priority | Assignee | Title |
4029756, | Nov 26 1975 | Research Corporation | Serological procedure for determining presence of neisseria gonorrhoeae antibodies |
4127318, | Sep 20 1975 | Ernst Leitz Wetzlar GmbH | Direct illumination apparatus for light and dark field illumination |
4255971, | Nov 01 1978 | Bankers Trust Company | Thermoacoustic microscopy |
4267732, | Nov 29 1978 | Stanford University Board of Trustees | Acoustic microscope and method |
4375818, | Mar 12 1979 | Olympus Optical Company Ltd. | Ultrasonic diagnosis system assembled into endoscope |
4385634, | Apr 24 1981 | ARIZONA, UNIVERSITY OF; TELETHERM CORPORATION; OPTOSONICS, INC | Radiation-induced thermoacoustic imaging |
4430897, | May 14 1981 | The Board of Trustees of the Leland Stanford University | Acoustic microscope and method |
4462255, | Feb 03 1983 | Technicare Corporation | Piezoelectric scanning systems for ultrasonic transducers |
4468136, | Feb 12 1982 | The Johns Hopkins University; JOHNS HOPKINS UNIVERSITY, THE, A CORP OF MD | Optical beam deflection thermal imaging |
4489727, | Mar 22 1981 | Olympus Optical Co., Ltd. | Device for diagnosing body cavity interior with supersonic waves |
4546771, | Jan 23 1980 | INDIANAPOLIS CENTER FOR ADVANCED RESEARCH, INC A CORP OF IN | Acoustic microscope |
4596254, | Dec 18 1984 | Optical Sensors Incorporated | Laser Doppler flow monitor |
4740081, | Mar 23 1985 | U S PHILIPS CORPORATION | Optical measuring apparatus |
4802461, | Aug 26 1987 | Candela Corporation | Rigid endoscope with flexible tip |
4802487, | Mar 26 1987 | WASHINGTON RESEARCH FOUNDATION, 1107 NORTHWEST 45TH ST , SUITE 322, SEATTLE, WA, A NONPROFIT CORP | Endoscopically deliverable ultrasound imaging system |
4809703, | Sep 29 1986 | Hitachi Medical Corp. | Ultrasonic doppler blood flow meter |
4850363, | Oct 16 1986 | Olympus Optical Co., Ltd. | Ultrasonic diagnostic apparatus with multiple focal lengths |
4860758, | Aug 14 1986 | Olympus Optical Co. Ltd. | Multiple diagnosable distance range ultrasonic diagnostic apparatus |
4869256, | Apr 22 1987 | Olympus Optical Co., Ltd. | Endoscope apparatus |
4921333, | Jan 11 1989 | The United States of America as represented by the Secretary of the Army | Phase contrast image microscopy using optical phase conjugation in a hybrid analog/digital design |
4995396, | Dec 08 1988 | Olympus Optical Co., Ltd. | Radioactive ray detecting endoscope |
5070455, | Nov 22 1989 | Singer Imaging, Inc. | Imaging system and method using scattered and diffused radiation |
5083549, | Feb 06 1989 | Candela Corporation | Endoscope with tapered shaft |
5107844, | Apr 06 1989 | OLYMPUS OPTICAL CO , LTD | Ultrasonic observing apparatus |
5115814, | Aug 18 1989 | Boston Scientific Scimed, Inc | Intravascular ultrasonic imaging probe and methods of using same |
5125410, | Oct 13 1989 | OLYMPUS OPTICAL CO , LTD | Integrated ultrasonic diagnosis device utilizing intra-blood-vessel probe |
5140463, | Mar 08 1990 | RESEARCH FOUNDATION OF CITY OF COLLEGE OF NEW YORK | Method and apparatus for improving the signal to noise ratio of an image formed of an object hidden in or behind a semi-opaque random media |
5170793, | Feb 07 1990 | Kabushiki Kaisha Toshiba | Ultrasonic probe |
5207672, | May 03 1989 | ENTERPRISE MEDICAL TECHNOLOGIES, INC | Instrument and method for intraluminally relieving stenosis |
5227912, | Oct 30 1991 | Multiple-stage optical Kerr gate system | |
5305759, | Sep 26 1990 | Olympus Optical Co., Ltd. | Examined body interior information observing apparatus by using photo-pulses controlling gains for depths |
5321501, | Apr 29 1991 | Massachusetts Institute of Technology | Method and apparatus for optical imaging with means for controlling the longitudinal range of the sample |
5331466, | Apr 23 1991 | Lions Eye Institute of Western Australia Inc. | Method and apparatus for homogenizing a collimated light beam |
5345938, | Sep 30 1991 | Kabushiki Kaisha Toshiba | Diagnostic apparatus for circulatory systems |
5373845, | May 22 1992 | ECHO CATH, INC | Apparatus and method for forward looking volume imaging |
5414623, | May 08 1992 | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC | Optoelectronic system for implementation of iterative computer tomography algorithms |
5445155, | Mar 13 1991 | Scimed Life Systems Incorporated | Intravascular imaging apparatus and methods for use and manufacture |
5465722, | Dec 11 1991 | Synthetic aperture ultrasound imaging system | |
5546947, | Sep 30 1993 | Terumo Kabushiki Kaisha | Ultrasonic endoprobe |
5546948, | Aug 21 1990 | Boston Scientific Corporation | Ultrasound imaging guidewire |
5606975, | Sep 19 1994 | The Board of Trustees of the Leland Stanford Junior University | Forward viewing ultrasonic imaging catheter |
5615675, | Apr 19 1996 | MICHIGAN, REGENTS OF THE UNIVERSITY OF | Method and system for 3-D acoustic microscopy using short pulse excitation and 3-D acoustic microscope for use therein |
5635784, | Feb 13 1995 | Bearingless ultrasound-sweep rotor | |
5651366, | Sep 19 1994 | Board of Trustees of the Leland Stanford Junior University | Forward viewing ultrasonic imaging catheter |
5713356, | Oct 04 1996 | SENCO BRANDS, INC | Photoacoustic breast scanner |
5718231, | Jun 15 1993 | British Technology Group Ltd. | Laser ultrasound probe and ablator |
5836872, | Apr 13 1989 | VANGUARD IMAGING LTD | Digital optical visualization, enhancement, quantification, and classification of surface and subsurface features of body surfaces |
5840023, | Jan 31 1996 | SENO MEDICAL INSTRUMENTS, INC | Optoacoustic imaging for medical diagnosis |
5860934, | Dec 21 1992 | PROUROCARE MEDICAL, INC ; PROUROCARE MEDICAL INC | Method and device for mechanical imaging of breast |
5913234, | Nov 05 1996 | ORBISPHERE LABORATORIES NEUCHATEL S A | Spectroscopic method and apparatus |
5971998, | Mar 31 1998 | Donald G., Russell; Stewart E., Bober | Support device and method for controlling breast thickness during stereotactic guided needle biopsy |
5991697, | Dec 31 1996 | CALIFORNIA, UNIVERSITY OF, REGENTS OF THE, THE | Method and apparatus for optical Doppler tomographic imaging of fluid flow velocity in highly scattering media |
6055097, | Feb 05 1993 | Carnegie Mellon University | Field synthesis and optical subsectioning for standing wave microscopy |
6102857, | Oct 04 1996 | SENCO BRANDS, INC | Photoacoustic breast scanner |
6104942, | May 12 1998 | SENTRON MEDICAL, INC | Thermoacoustic tissue scanner |
6108576, | Feb 07 1997 | RESEARCH FOUNDATION OF CITY COLLEGE OF NEW YORK, THE | Time-resolved diffusion tomographic 2D and 3D imaging in highly scattering turbid media |
6111645, | Apr 29 1991 | Massachusetts Institute of Technology | Grating based phase control optical delay line |
6134003, | Apr 29 1991 | General Hospital Corporation, The | Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope |
6216025, | Feb 02 1999 | SENTRON MEDICAL, INC | Thermoacoustic computed tomography scanner |
6233055, | Mar 13 1998 | Optical Biopsy Technologies, Inc.; OPTICAL BIOPSY TECHNOLOGIES, INC | Method and apparatus for performing optical coherence-domain reflectometry and imaging through a scattering medium |
6282011, | Apr 29 1991 | Massachusetts Institute of Technology | Grating based phase control optical delay line |
6292682, | Oct 04 1996 | SENTRON MEDICAL, INC | Photoacoustic breast scanner |
6309352, | Jan 31 1996 | Board of Regents, The University of Texas System | Real time optoacoustic monitoring of changes in tissue properties |
6341036, | Feb 26 1998 | The General Hospital Corporation | Confocal microscopy with multi-spectral encoding |
6379325, | Apr 24 1996 | Lawrence Livermore National Security LLC | Opto-acoustic transducer for medical applications |
6405069, | Jan 31 1996 | Board of Regents, The University of Texas System | Time-resolved optoacoustic method and system for noninvasive monitoring of glucose |
6413228, | Dec 28 1998 | ATOSSA THERAPEUTICS, INC | Devices, methods and systems for collecting material from a breast duct |
6421164, | Apr 29 1991 | Massachusetts Institute of Technology | Interferometeric imaging with a grating based phase control optical delay line |
6432067, | Oct 31 1997 | SONIC CONCEPTS, INC | Method and apparatus for medical procedures using high-intensity focused ultrasound |
6466806, | May 17 2000 | LIFEWATCH TECHNOLOGIES LTD | Photoacoustic material analysis |
6485413, | Apr 29 1991 | General Hospital Corporation, The | Methods and apparatus for forward-directed optical scanning instruments |
6490470, | Jun 19 2001 | KYOCERA SENCO INDUSTRIAL TOOLS, INC | Thermoacoustic tissue scanner |
6498942, | Aug 06 1999 | Board of Regents, The University of Texas System | Optoacoustic monitoring of blood oxygenation |
6498945, | May 19 1997 | GE HEALTHCARE AS | Sonodynamic therapy using an ultrasound sensitizer compound |
6501551, | Apr 29 1991 | Massachusetts Institute of Technology | Fiber optic imaging endoscope interferometer with at least one faraday rotator |
6564087, | Apr 29 1991 | Massachusetts Institute of Technology | Fiber optic needle probes for optical coherence tomography imaging |
6567688, | Aug 19 1999 | The Texas A&M University System | Methods and apparatus for scanning electromagnetically-induced thermoacoustic tomography |
6626834, | Jan 25 2001 | OPTOS PLC | Spiral scanner with electronic control |
6633774, | Jun 19 2001 | KYOCERA SENCO INDUSTRIAL TOOLS, INC | Thermoacoustic tissue scanner |
6654630, | May 31 2001 | INFRAREDX, INC | Apparatus and method for the optical imaging of tissue samples |
6658279, | Oct 28 1996 | EP Technologies, Inc. | Ablation and imaging catheter |
6694173, | Nov 12 1999 | Non-contact photoacoustic spectroscopy for photoablation control | |
6701181, | May 31 2001 | INFRAREDX, INC | Multi-path optical catheter |
6751490, | Mar 01 2000 | The Board of Regents of the University of Texas System | Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit |
6764450, | Feb 28 1986 | SciMed Life Systems, Inc. | Method and apparatus for intravascular two-dimensional ultrasonography |
6831781, | Feb 26 1998 | General Hospital Corporation, The | Confocal microscopy with multi-spectral encoding and system and apparatus for spectroscopically encoded confocal microscopy |
6833540, | Mar 07 1997 | Abbott Laboratories | System for measuring a biological parameter by means of photoacoustic interaction |
6839496, | Jun 28 1999 | LONDON, UNIVERISTY COLLEGE | Optical fibre probe for photoacoustic material analysis |
6846288, | Aug 24 2000 | PHC HOLDINGS CORPORATION | Photoacoustic assay and imaging system |
6877894, | Sep 24 2002 | SIEMENS ENERGY, INC | Self-aligning apparatus for acoustic thermography |
6937886, | Oct 18 1996 | CALIBER IMAGING & DIAGNOSTICS, INC | System for confocal imaging within dermal tissue |
6956650, | Jan 12 2001 | General Hospital Corporation | System and method for enabling simultaneous calibration and imaging of a medium |
7072045, | Jan 16 2002 | The Regents of the University of California | High resolution optical coherence tomography with an improved depth range using an axicon lens |
7198778, | Jan 18 2000 | Mallinckrodt Inc | Tumor-targeted optical contrast agents |
7231243, | Oct 30 2000 | The General Hospital Corporation | Optical methods for tissue analysis |
7245789, | Oct 07 2002 | PHYZHON HEALTH INC | Systems and methods for minimally-invasive optical-acoustic imaging |
7266407, | Nov 17 2003 | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC | Multi-frequency microwave-induced thermoacoustic imaging of biological tissue |
7322972, | Apr 10 2002 | Regents of the University of California, The | In vivo port wine stain, burn and melanin depth determination using a photoacoustic probe |
7357029, | Mar 31 2004 | Quantum Focus Instruments Corporation | Thermal-acoustic scanning systems and methods |
7382949, | Nov 02 2004 | The General Hospital Corporation | Fiber-optic rotational device, optical system and method for imaging a sample |
7541602, | Jun 04 2007 | OR-NIM MEDICAL LTD | System and method for noninvasively monitoring conditions of a subject |
7917312, | Oct 18 2007 | California Institute of Technology | Photoacoustic doppler flow sensing and imaging |
8016419, | Mar 17 2009 | University of Southern California | Systems and methods for photoacoustic opthalmoscopy |
8025406, | Mar 17 2009 | University of Southern California | Systems and methods for photoacoustic opthalmoscopy |
8143605, | Jun 04 2007 | OR-NIM Medical Ltd. | System and method for non-invasively monitoring conditions of a object |
8397573, | Sep 10 2008 | Canon Kabushiki Kaisha | Photoacoustic apparatus |
8416421, | Oct 01 2008 | California Institute of Technology | Optical coherence computed tomography |
8454512, | Oct 24 2008 | Washington University | Confocal photoacoustic microscopy with optical lateral resolution |
20010052979, | |||
20020176092, | |||
20030097066, | |||
20030160957, | |||
20030160967, | |||
20040039379, | |||
20040082070, | |||
20050015002, | |||
20050143664, | |||
20050154313, | |||
20050217381, | |||
20060055936, | |||
20060058614, | |||
20060122516, | |||
20060181791, | |||
20060184042, | |||
20060235299, | |||
20060264717, | |||
20070088206, | |||
20070213590, | |||
20070213618, | |||
20070282200, | |||
20070299341, | |||
20080088838, | |||
20080173093, | |||
20080194929, | |||
20080230717, | |||
20090088631, | |||
20090116518, | |||
20090138215, | |||
20100079768, | |||
20100245766, | |||
20100245769, | |||
20100245770, | |||
20100249562, | |||
20100268042, | |||
20100285518, | |||
20100309466, | |||
20110071402, | |||
20110122416, | |||
20110201914, | |||
20110275890, | |||
20110282181, | |||
20110282192, | |||
20120070817, | |||
20120204648, | |||
20120275262, | |||
20120307250, | |||
20130245406, | |||
20140009808, | |||
20140142404, | |||
EP12262, | |||
EP1493380, | |||
JP2000292416, | |||
JP2009068977, | |||
JP2010017426, | |||
JP5126725, | |||
WO2006111929, | |||
WO2007148239, | |||
WO2008062354, | |||
WO2008100386, | |||
WO2009055705, | |||
WO2010048258, | |||
WO2010080991, | |||
WO2011091360, | |||
WO2011127428, | |||
WO2013086293, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 16 2010 | WANG, LIHONG | Washington University | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029182 | /0068 | |
Feb 16 2010 | GUO, ZIJIAN | Washington University | ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS | 029182 | /0068 | |
Jun 07 2016 | Washington University | NATIONAL INSTITUTES OF HEALTH NIH , U S DEPT OF HEALTH AND HUMAN SERVICES DHHS , U S GOVERNMENT | CONFIRMATORY LICENSE SEE DOCUMENT FOR DETAILS | 039266 | /0101 |
Date | Maintenance Fee Events |
Apr 19 2017 | ASPN: Payor Number Assigned. |
Jan 14 2019 | M2551: Payment of Maintenance Fee, 4th Yr, Small Entity. |
Jan 12 2023 | M2552: Payment of Maintenance Fee, 8th Yr, Small Entity. |
Date | Maintenance Schedule |
Jul 21 2018 | 4 years fee payment window open |
Jan 21 2019 | 6 months grace period start (w surcharge) |
Jul 21 2019 | patent expiry (for year 4) |
Jul 21 2021 | 2 years to revive unintentionally abandoned end. (for year 4) |
Jul 21 2022 | 8 years fee payment window open |
Jan 21 2023 | 6 months grace period start (w surcharge) |
Jul 21 2023 | patent expiry (for year 8) |
Jul 21 2025 | 2 years to revive unintentionally abandoned end. (for year 8) |
Jul 21 2026 | 12 years fee payment window open |
Jan 21 2027 | 6 months grace period start (w surcharge) |
Jul 21 2027 | patent expiry (for year 12) |
Jul 21 2029 | 2 years to revive unintentionally abandoned end. (for year 12) |